The report "Prostate Cancer Diagnostic Market By Test Type (Tumor Biomarker Tests, Imaging, Biopsy, Other) By Cancer Stage (Stage I, Stage II A, Stage II B, Stage III, Stage IV), By End User (Hospital Associated Labs, Independent Diagnostic Labs, Diagnostic Imaging Centers, Cancer Research Institutes, Others) - Global Forecasts to 2030"
The global prostate cancer diagnostic market is projected to reach USD 126.5 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 8.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the innovation in drugs and developments in genomics and proteomics
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22416
Competitive Dashboard:
The prominent key players operating in the global prostate cancer diagnostic market are Accuquik Test Kits (U.S.), ACON Laboratories, Inc. (U.S.), bioMérieux SA (France), HUMASIS (South Korea), Teco Diagnostics (U.S.), Hologic Inc. (U.S.), MDxHealthcare (Belgium), Abbott (U.S.), Siemens Healthcare GmbH (Germany), OPKO Health Inc. (U.S.), Myriad Genetics, Inc. (U.S.), DiaSorin S.p.A (Italy), Beckman Coulter, Inc. (a subsidiary of Danaher) (U.S.), Metamark Genetics, Inc. (U.S.), Prostatype Genomics (Switzerland), Fujirebio (Belgium), Proteomedix (Switzerland), Eurolyser Diagnostica GmbH (Austria), F. Hoffmann-La Roche Ltd (Switzerland)
Regional Overview:
The report also examines the current concerns and their Future Effects on the Prostate Cancer Diagnostic Market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the Prostate Cancer Diagnostic Market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
A Few Points from the Table of Contents –
1. Executive Summary
2. Global Prostate Cancer Diagnostic Market Introduction
3. Global Prostate Cancer Diagnostic Market Dynamics
4. Global Prostate Cancer Diagnostic Market Analysis, 2019 - 2023 and Forecast 2024 – 2030
……………….
9. Global Prostate Cancer Diagnostic Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10. North America Prostate Cancer Diagnostic Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11. Europe Prostate Cancer Diagnostic Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12. Asia Pacific (APAC) Prostate Cancer Diagnostic Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13. Middle East and Africa (MEA) Prostate Cancer Diagnostic Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
14. Latin America Prostate Cancer Diagnostic Market 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
15. Competition Landscape
16. Research Methodology
17. Appendix and Abbreviations
Scope of The Report:
- The prostate cancer diagnostic market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The prostate cancer diagnostic market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The prostate cancer diagnostic market key players covered here to help them strengthen their place in the market.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
